Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

20 oct. 2023 12h48 HE | Source: Visiongain Reports Ltd

Antisense Oligonucleotide (ASO) Therapeutics market is projected to grow at a CAGR of 14.5% by 2033: Visiongain

Visiongain has published a new report entitled Antisense Oligonucleotide (ASO) Therapeutics Market Report 2023-2033: Forecasts by Therapeutic Application (Neurological Disorders, Genetic Disorders,...
19 avr. 2022 10h00 HE | Source: Visiongain Ltd

Antisense Oligonucleotide (ASO) Therapeutics Market Report Up to 2031, By Visiongain Research Inc

Visiongain has launched a new report Antisense Oligonucleotide (ASO) Therapeutics Market Report 2021-2031: Forecasts by Therapeutic Area (Genetic Disorders, Neurological Disorders, Oncological...